AAPL334.51+2.24 (+0.67%) ▲|ABBV261.68+4.56 (+1.77%) ▲|ABT102.73+0.78 (+0.77%) ▲|ACN194.40+10.50 (+5.71%) ▲|ADBE263.56+11.33 (+4.49%) ▲|AMAT426.19-30.30 (-6.64%) ▼|AMD495.42-20.71 (-4.01%) ▼|AMGN380.80+3.45 (+0.91%) ▲|AMT177.21-0.65 (-0.36%) ▼|AMZN253.96-2.82 (-1.10%) ▼|AVGO344.37-17.63 (-4.87%) ▼|AXP327.64+2.95 (+0.91%) ▲|BA209.92-0.54 (-0.25%) ▼|BAC59.40-3.30 (-5.26%) ▼|BKNG175.50+1.58 (+0.91%) ▲|BLK1,066.15-13.50 (-1.25%) ▼|BMY64.04+0.40 (+0.63%) ▲|BNY157.59-5.07 (-3.12%) ▼|BRK-B515.18+4.81 (+0.94%) ▲|C137.11-1.71 (-1.23%) ▼|CAT784.88-33.69 (-4.12%) ▼|CL88.27+1.47 (+1.69%) ▲|CMCSA24.89-0.32 (-1.25%) ▼|COF207.02-1.29 (-0.62%) ▼|COP136.34-1.01 (-0.74%) ▼|COST920.04+15.27 (+1.69%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.31-1.82 (-1.62%) ▼|CVS95.76+1.10 (+1.16%) ▲|CVX211.80-2.26 (-1.06%) ▼|DE680.83+5.09 (+0.75%) ▲|DHR202.76+2.62 (+1.31%) ▲|DIS108.79+2.24 (+2.10%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.27-3.92 (-2.58%) ▼|FDX312.06+1.29 (+0.42%) ▲|GD357.32+1.42 (+0.40%) ▲|GE317.53-6.13 (-1.89%) ▼|GEV873.21-84.06 (-8.78%) ▼|GILD146.23+2.51 (+1.75%) ▲|GM87.09+1.47 (+1.72%) ▲|GOOG344.74+9.29 (+2.77%) ▲|GOOGL348.22+9.72 (+2.87%) ▲|GS989.32-39.86 (-3.87%) ▼|HD311.65+2.91 (+0.94%) ▲|HON201.22-1.15 (-0.57%) ▼|IBM249.31+6.02 (+2.47%) ▲|INTC97.54-5.41 (-5.25%) ▼|INTU339.28+17.71 (+5.51%) ▲|ISRG378.26+9.11 (+2.47%) ▲|JNJ267.06+1.48 (+0.56%) ▲|JPM350.09-6.14 (-1.72%) ▼|KO89.24+0.95 (+1.07%) ▲|LIN463.08-3.14 (-0.67%) ▼|LLY1,138.90+23.20 (+2.08%) ▲|LMT530.83+6.64 (+1.27%) ▲|LOW198.79+1.97 (+1.00%) ▲|LRCX274.88-23.34 (-7.83%) ▼|MA572.51+3.32 (+0.58%) ▲|MCD257.40+4.87 (+1.93%) ▲|MDLZ62.31-0.14 (-0.22%) ▼|MDT93.74+2.78 (+3.05%) ▲|META666.95+18.92 (+2.92%) ▲|MMM162.12-2.85 (-1.73%) ▼|MO70.60+1.62 (+2.34%) ▲|MRK144.64+0.71 (+0.49%) ▲|MS207.34-7.05 (-3.29%) ▼|MSFT507.36+11.73 (+2.37%) ▲|MU927.33-47.93 (-4.91%) ▼|NEE81.77-0.54 (-0.66%) ▼|NFLX80.41+3.01 (+3.89%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.45+9.92 (+7.48%) ▲|NVDA211.77-6.52 (-2.99%) ▼|ORCL143.52-6.77 (-4.50%) ▼|PEP136.41+0.09 (+0.07%) ▲|PFE27.74+0.02 (+0.07%) ▲|PG146.09+0.82 (+0.56%) ▲|PLTR173.86+6.63 (+3.96%) ▲|PM194.39+3.33 (+1.74%) ▲|QCOM180.40-1.57 (-0.86%) ▼|RTX195.05-2.64 (-1.33%) ▼|SBUX99.12+0.38 (+0.38%) ▲|SCHW107.25+0.00 (+0.00%) ▲|SO86.77-0.40 (-0.46%) ▼|SPG204.77-0.06 (-0.03%) ▼|T26.57+0.51 (+1.94%) ▲|TMO611.41+1.59 (+0.26%) ▲|TMUS182.41+0.08 (+0.04%) ▲|TSLA360.37-5.07 (-1.39%) ▼|TXN263.76-4.95 (-1.84%) ▼|UBER72.57+0.90 (+1.25%) ▲|UNH383.76+6.99 (+1.86%) ▲|UNP284.89+0.49 (+0.17%) ▲|UPS102.33+2.05 (+2.04%) ▲|USB62.62-0.23 (-0.36%) ▼|V374.27+3.82 (+1.03%) ▲|VZ51.33+0.72 (+1.43%) ▲|WFC88.60-1.69 (-1.87%) ▼|WMT109.53+2.38 (+2.22%) ▲|XOM164.53-1.46 (-0.88%) ▼|AAPL334.51+2.24 (+0.67%) ▲|ABBV261.68+4.56 (+1.77%) ▲|ABT102.73+0.78 (+0.77%) ▲|ACN194.40+10.50 (+5.71%) ▲|ADBE263.56+11.33 (+4.49%) ▲|AMAT426.19-30.30 (-6.64%) ▼|AMD495.42-20.71 (-4.01%) ▼|AMGN380.80+3.45 (+0.91%) ▲|AMT177.21-0.65 (-0.36%) ▼|AMZN253.96-2.82 (-1.10%) ▼|AVGO344.37-17.63 (-4.87%) ▼|AXP327.64+2.95 (+0.91%) ▲|BA209.92-0.54 (-0.25%) ▼|BAC59.40-3.30 (-5.26%) ▼|BKNG175.50+1.58 (+0.91%) ▲|BLK1,066.15-13.50 (-1.25%) ▼|BMY64.04+0.40 (+0.63%) ▲|BNY157.59-5.07 (-3.12%) ▼|BRK-B515.18+4.81 (+0.94%) ▲|C137.11-1.71 (-1.23%) ▼|CAT784.88-33.69 (-4.12%) ▼|CL88.27+1.47 (+1.69%) ▲|CMCSA24.89-0.32 (-1.25%) ▼|COF207.02-1.29 (-0.62%) ▼|COP136.34-1.01 (-0.74%) ▼|COST920.04+15.27 (+1.69%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.31-1.82 (-1.62%) ▼|CVS95.76+1.10 (+1.16%) ▲|CVX211.80-2.26 (-1.06%) ▼|DE680.83+5.09 (+0.75%) ▲|DHR202.76+2.62 (+1.31%) ▲|DIS108.79+2.24 (+2.10%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.27-3.92 (-2.58%) ▼|FDX312.06+1.29 (+0.42%) ▲|GD357.32+1.42 (+0.40%) ▲|GE317.53-6.13 (-1.89%) ▼|GEV873.21-84.06 (-8.78%) ▼|GILD146.23+2.51 (+1.75%) ▲|GM87.09+1.47 (+1.72%) ▲|GOOG344.74+9.29 (+2.77%) ▲|GOOGL348.22+9.72 (+2.87%) ▲|GS989.32-39.86 (-3.87%) ▼|HD311.65+2.91 (+0.94%) ▲|HON201.22-1.15 (-0.57%) ▼|IBM249.31+6.02 (+2.47%) ▲|INTC97.54-5.41 (-5.25%) ▼|INTU339.28+17.71 (+5.51%) ▲|ISRG378.26+9.11 (+2.47%) ▲|JNJ267.06+1.48 (+0.56%) ▲|JPM350.09-6.14 (-1.72%) ▼|KO89.24+0.95 (+1.07%) ▲|LIN463.08-3.14 (-0.67%) ▼|LLY1,138.90+23.20 (+2.08%) ▲|LMT530.83+6.64 (+1.27%) ▲|LOW198.79+1.97 (+1.00%) ▲|LRCX274.88-23.34 (-7.83%) ▼|MA572.51+3.32 (+0.58%) ▲|MCD257.40+4.87 (+1.93%) ▲|MDLZ62.31-0.14 (-0.22%) ▼|MDT93.74+2.78 (+3.05%) ▲|META666.95+18.92 (+2.92%) ▲|MMM162.12-2.85 (-1.73%) ▼|MO70.60+1.62 (+2.34%) ▲|MRK144.64+0.71 (+0.49%) ▲|MS207.34-7.05 (-3.29%) ▼|MSFT507.36+11.73 (+2.37%) ▲|MU927.33-47.93 (-4.91%) ▼|NEE81.77-0.54 (-0.66%) ▼|NFLX80.41+3.01 (+3.89%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.45+9.92 (+7.48%) ▲|NVDA211.77-6.52 (-2.99%) ▼|ORCL143.52-6.77 (-4.50%) ▼|PEP136.41+0.09 (+0.07%) ▲|PFE27.74+0.02 (+0.07%) ▲|PG146.09+0.82 (+0.56%) ▲|PLTR173.86+6.63 (+3.96%) ▲|PM194.39+3.33 (+1.74%) ▲|QCOM180.40-1.57 (-0.86%) ▼|RTX195.05-2.64 (-1.33%) ▼|SBUX99.12+0.38 (+0.38%) ▲|SCHW107.25+0.00 (+0.00%) ▲|SO86.77-0.40 (-0.46%) ▼|SPG204.77-0.06 (-0.03%) ▼|T26.57+0.51 (+1.94%) ▲|TMO611.41+1.59 (+0.26%) ▲|TMUS182.41+0.08 (+0.04%) ▲|TSLA360.37-5.07 (-1.39%) ▼|TXN263.76-4.95 (-1.84%) ▼|UBER72.57+0.90 (+1.25%) ▲|UNH383.76+6.99 (+1.86%) ▲|UNP284.89+0.49 (+0.17%) ▲|UPS102.33+2.05 (+2.04%) ▲|USB62.62-0.23 (-0.36%) ▼|V374.27+3.82 (+1.03%) ▲|VZ51.33+0.72 (+1.43%) ▲|WFC88.60-1.69 (-1.87%) ▼|WMT109.53+2.38 (+2.22%) ▲|XOM164.53-1.46 (-0.88%) ▼|
23.9 C
New York
Monday, September 14, 2026

Tag: share

Cancer Pain Market Set to Transform by 2034 Due to Launch of Breakthrough Therapies | DelveInsight

According to DelveInsight's analysis, the growth of the cancer pain market is expected to be mainly driven by increasing incidence and advances in disease...

FOBI AI Inc. Announces Closing of the Sale of German Subsidiary

Vancouver, BC, June 12, 2025 (GLOBE NEWSWIRE) -- FOBI AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (“Fobi” or the “Company”) announces that further to its news release dated May 28, 2025, it has closed the sale (the “Transaction”) of all of its shares in Fobi AI Germany GmbH (the “Acquired Company”), its wholly owned German subsidiary, to an arm’s length third party purchaser (the “Purchaser”) pursuant to the terms of share purchase agreement dated May 28, 2025 (the “Agreement”).

RCKT INVESTOR ALERT: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead the Rocket Pharmaceuticals Class Action Lawsuit

SAN DIEGO, June 12, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT)...

Draganfly Announces Closing of US$13.75 Million Public Offering

Saskatoon, SK., June 12, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), a drone solutions, and systems developer, today announced the closing of its previously announced public offering (the “Offering”) of 5,500,000 units, with each unit consisting of one common share and one warrant to purchase one common share. Each unit was sold at a public offering price of US$2.50, for gross proceeds of approximately US$13.75 million, before deducting placement agent discounts and offering expenses. The warrants have an exercise price of CA$5.0768 (or US$3.71) per share, are exercisable immediately and will expire five years following the date of issuance.

InterDigital Declares Regular Quarterly Cash Dividend

WILMINGTON, Del., June 12, 2025 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.60 per share on its common stock payable on July 23, 2025, to shareholders of record at the close of business on July 9, 2025.

[Latest] Global Pharmaceutical Glass Packaging Market Size/Share Worth USD 49.20 Billion by 2034 at a 7.87% CAGR: Business Research Industry (Analysis, Outlook, Leaders, Report,...

[220+ Pages Latest Report] According to a market research study published by Business Research Industry, the demand analysis of Global Pharmaceutical Glass Packaging Market size & share revenue was valued at approximately USD 23.36 Billion in 2024 and is expected to reach USD 24.87 Billion in 2025 and is expected to reach around USD 49.20 Billion by 2034, at a CAGR of 7.87% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Corning Incorporated, Nipro Corporation, SGD S.A., Stoelzle Oberglas GmbH, Bormioli Pharma S.p.A., West Pharmaceutical Services Inc., Schott AG, Gerresheimer AG, Shandong Medicinal Glass Co. Ltd., Beatson Clark, Ardagh Group S.A, Arab Pharmaceutical Glass Co., Piramal Enterprises Ltd., Şişecam Group, Owens-Illinois Inc., DWK Life sciences, and others.
[220+ Pages Latest Report] According to a market research study published by Business Research Industry, the demand analysis of Global Pharmaceutical Glass Packaging Market size & share revenue was valued at approximately USD 23.36 Billion in 2024 and is expected to reach USD 24.87 Billion in 2025 and is expected to reach around USD 49.20 Billion by 2034, at a CAGR of 7.87% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Corning Incorporated, Nipro Corporation, SGD S.A., Stoelzle Oberglas GmbH, Bormioli Pharma S.p.A., West Pharmaceutical Services Inc., Schott AG, Gerresheimer AG, Shandong Medicinal Glass Co. Ltd., Beatson Clark, Ardagh Group S.A, Arab Pharmaceutical Glass Co., Piramal Enterprises Ltd., Şişecam Group, Owens-Illinois Inc., DWK Life sciences, and others.

W. P. Carey Increases Quarterly Dividend to $0.900 per Share

NEW YORK, June 12, 2025 /PRNewswire/ -- W. P. Carey Inc. (W. P. Carey, NYSE: WPC) reported today that its Board of Directors increased its...

Carrier Board of Directors Declares Quarterly Cash Dividend

PALM BEACH GARDENS, Fla., June 12, 2025 /PRNewswire/ -- Carrier Global Corporation (NYSE: CARR), global leader in intelligent climate and energy solutions, announced today...

Atrium Mortgage Investment Corporation Announces $30 Million Public Offering of Convertible Unsecured Subordinated Debentures

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

New York Mortgage Trust Declares Second Quarter 2025 Common Stock Dividend of $0.20 Per Share, and Preferred Stock Dividends

NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) announced today that its Board of Directors (the “Board”) declared a regular quarterly cash dividend of $0.20 per share on shares of its common stock for the quarter ending June 30, 2025. The dividend will be payable on July 30, 2025 to common stockholders of record as of the close of business on June 23, 2025.

Absecon Bancorp Declares Second-Quarter Cash Dividend of $0.90 Per Share

ABSECON, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Absecon Bancorp (the “Company”) (OTC, trading as ASCN), the bank holding company of First National Bank of Absecon, an Atlantic County New Jersey based community bank, announced today that its Board of Directors declared a regular quarterly cash dividend in the amount of $0.90 per share, payable on June 30, 2025 to shareholders of record as of June 20, 2025.

Urano Energy Announces Completion of Upsized Private Placement

/NOT FOR DISTRIBUTION IN THE UNITED STATES/ CSE: UEOTCQB: UECXFwww.uranoenergy.com VANCOUVER, BC, June 12, 2025 /CNW/ - Urano Energy Corp, (CSE: UE | OTCQB: UECXF)...

FibroGen Announces 1-for-25 Reverse Stock Split

SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and outstanding common stock ("Reverse Stock Split"), effective at 5:00 p.m. Eastern Time on June 16, 2025. FibroGen’s common stock will begin trading on a split-adjusted basis on June 17, 2025, when the markets open, under the Company’s existing trading symbol “FGEN,” with the new CUSIP number 31572Q881.

Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL

Data reported from the ongoing ATALANTA-1 Phase 1/2 study in a heavily pretreated relapsed refractory non-Hodgkin’s Lymphoma (R/R NHL) patient population demonstrate low rates of high-grade toxicities

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsShare